Skip to Main Content

Paper Details

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer.
World J Urol
10
2020
Author NameAffiliation
Claudia Hube-MaggInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Martina KluthInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Hartwig HulandMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Markus GraefenMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Ronald SimonInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Guido SauterInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Thorsten SchlommUniversitatsmedizin Berlin
  • 1 - 7

Datasets

Release 1.2